The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis()

The overall 5-year survival for melanoma is 91%. However, if distant metastasis occurs (stage IV), cure rates are < 15%. Hence, melanoma detection in earlier stages (stages I–III) maximises the chances of patient survival. We measured the expression of a panel of 17 microRNAs (miRNAs) (MELmiR-17)...

Descripción completa

Detalles Bibliográficos
Autores principales: Stark, Mitchell S., Klein, Kerenaftali, Weide, Benjamin, Haydu, Lauren E., Pflugfelder, Annette, Tang, Yue Hang, Palmer, Jane M., Whiteman, David C., Scolyer, Richard A., Mann, Graham J., Thompson, John F., Long, Georgina V., Barbour, Andrew P., Soyer, H. Peter, Garbe, Claus, Herington, Adrian, Pollock, Pamela M., Hayward, Nicholas K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534690/
https://www.ncbi.nlm.nih.gov/pubmed/26288839
http://dx.doi.org/10.1016/j.ebiom.2015.05.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534690/
https://www.ncbi.nlm.nih.gov/pubmed/26288839
http://dx.doi.org/10.1016/j.ebiom.2015.05.011

Ejemplares similares